SITC Archive Library

Industry Program: Novel Multi-Targeted Therapeutic Platforms: Session 2: Novel Platforms and Innovation 

10-16-2019 12:48

The Society for Immunotherapy of Cancer (SITC) hosted the "Novel Multi-Targeted Therapeutic Platforms" program during the SITC 2019 Annual Meeting on November 6, 2019. Available here are the presentation slides and video from "Session 2: Novel Platforms and Innovation."

Program Summary

With the approval of the first bispecific T-cell engager in 2018, and with many more such multi-targeted antibodies in clinical trials, there has been a resurgence of interest in these multi-functional platforms. Other related platforms, such as cytokine fusions and CAR T cell approaches, are also making their mark on the cancer treatment landscape. As these agents make their way into the clinic, however, many important scientific and clinical questions have been raised. During this half-day program, multi-targeted therapeutic platforms were discussed by experts in the field.

Program Organizers

  • Alessandra Cesano, MD, PhD – ESSA Pharma Inc.
  • Edward Cha, MD, PhD – Genentech
  • Leena Gandhi, MD, PhD – Eli Lilly
  • Israel Lowy, MD, PhD – Regeneron Pharmaceuticals
  • Salil Patel, PhD – Bristol-Myers Squibb
  • Eric Rubin, MD – Merck & Co., Inc.

Session Organizer
  • Eric Rubin, MD – Merck & Co., Inc.


To view the entire program schedule (including presenter permission to post) please click here.

Statistics
0 Favorited
102 Views
8 Files
0 Shares
144 Downloads

 Video
Attachment(s)
pdf file
checkpoint blockade, immune resilience, and stemness to ...   2.58 MB   1 version
Uploaded - 12-11-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Francesco M. Marincola, MD – Refuge Biotechnologies; Date: November 6, 2019
mp4 file
checkpoint blockade, immune resilience, and stemness to ...   109.86 MB   1 version
Uploaded - 12-16-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Francesco M. Marincola, MD – Refuge Biotechnologies; Date: November 6, 2019
pdf file
4-1BB Bicycle® peptide induces tumor localized 4-1BB agon...   2.62 MB   1 version
Uploaded - 12-11-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Nicholas Keen, PhD – Bicycle Therapeutics; Date: November 6, 2019
mp4 file
4-1BB Bicycle® peptide induces tumor localized 4-1BB agon...   111.77 MB   1 version
Uploaded - 12-16-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Nicholas Keen, PhD – Bicycle Therapeutics; Date: November 6, 2019
pdf file
"Combining CD27 costimulation and PD-1 blockade into a bi...   1.49 MB   1 version
Uploaded - 12-11-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Tibor Keler, PhD – Celldex Therapeutics, Inc.; Date: November 6, 2019
mp4 file
"Combining CD27 costimulation and PD-1 blockade into a bi...   106.48 MB   1 version
Uploaded - 12-16-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Tibor Keler, PhD – Celldex Therapeutics, Inc.; Date: November 6, 2019
pdf file
"The uniqueness and persistence of clonal profiles associ...   1.05 MB   1 version
Uploaded - 12-11-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Viktoria Gontcharova, PhD – Iovance Biotherapeutics; Date: November 6, 2019
mp4 file
"The uniqueness and persistence of clonal profiles associ...   110.04 MB   1 version
Uploaded - 12-16-2019
Meeting: SITC 34th Annual Meeting; Industry Program: Novel Multi-Targeted Therapeutic Platforms; Session 2: Novel Platforms and Innovation; Presenter: Viktoria Gontcharova, PhD – Iovance Biotherapeutics; Date: November 6, 2019

Related Entries and Links

No Related Resource entered.